ABSTRACT The activities of three erythrocyte (rbc) enzymes, arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N), were compared in 16 lead workers and 14 age matched controls as correlates of blood lead (PbB) and unextracted zinc protoporphyrin (EP) concentrations. Subjects with PbB of 0 9-2 5 pM (19-52 pg/dl) had 6-5 + 06 IU of P5N activity with uridine monophosphate (UMP) as substrate, significantly less (p < 0001) than the 12-0 + 07 IU activity of controls with PbB 0-3-0-6 MM (6-12 pg/dl). The mean activity of rbc dP5N with either deoxyuridine monophosphate (dUMP) or thymidine monophosphate as substrate, and of rbc arginase, did not differentiate the two groups. The correlation coefficients of ln PbB with the selected substrates for P5N and dP5N were: UMP, r = -0-75; dUMP, r = -0-61; TMP, r = -0*23. The correlation coefficient of ln PbB and arginase activity was -0-03. Rbc P5N (UMPase) is a significant correlate of PbB, equivalent to rbc protoporphyrin. HPLC assay of rbc UMPase activity is a sensitive and rapid assay that appears to meet criteria for a reliable clinical laboratory index of blood lead concentrations.
IU activity of controls with PbB 0-3-0-6 MM (6) (7) (8) (9) (10) (11) (12) pg/dl). The mean activity of rbc dP5N with either deoxyuridine monophosphate (dUMP) or thymidine monophosphate as substrate, and of rbc arginase, did not differentiate the two groups. The correlation coefficients of ln PbB with the selected substrates for P5N and dP5N were: UMP, r = -0-75; dUMP, r = -0-61; TMP, r = -0*23. The correlation coefficient of ln PbB and arginase activity was -0-03. Rbc P5N (UMPase) is a significant correlate of PbB, equivalent to rbc protoporphyrin. HPLC assay of rbc UMPase activity is a sensitive and rapid assay that appears to meet criteria for a reliable clinical laboratory index of blood lead concentrations.
The analytical variability in blood lead determinations whether by atomic absorption, anodic stripping voltametry, or other available methods has provoked wide ranging searches for reliable biochemical correlates. After the first two months of lead exposure, erythrocyte 5-aminolaevulinic dehydratase (ALA-D) activity is considered the most sensitive correlate with an apparent zero threshold for inhibition by lead. ALA-D activity is also decreased by zinc deficiency and carbon monoxide or alcohol exposure but the mode of assay is a major deterrent to clinical use.' Extracted and unextracted erythrocyte protophorphyrins (EP) are widely used in clinical screening at low levels of PbB but are considered insufficiently sensitive to assess occupational toxicity. In a new approach Fukumoto et al reported the correlation of rbc arginase with PbB, > 1 9 MM (>40 ug/dl).2 The stability of blood samples spotted on filter paper and an automated arginase assay suggested that this procedure had potential clinical use in evaluating exposure in lead workers.
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The present study was designed to investigate correlations between PbB and EP concentrations with rbc arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5 '-nucleotidase (dP5N 4-5 mm ID, 5 gm particle diameter) was used with a Brownlee guard cartridge (RP-18 Spheri 5). Both column and guard cartridge were purchased from Rainin Instruments, Woburn, MA. The HPLC mobile phase contained 001M KH2PO4, pH 4-0, with 4-10% methanol as described.'0 Uridine was eluted in about six minutes using 5-6% methanol. Product areas were obtained using external standards and a Spectra-Physics 4270 integrating recorder (San Jose, CA). Haemolysate haemoglobin concentrations were determined by the cyanmethaemoglobin procedure. International units (IU) of activity were calculated as umol nucleoside/h/g haemoglobin. All values are expressed as the mean + the standard error of the mean (SEM).
We also examined the effect on arginase activity of in vitro lead addition by adding lead nitrate at 1-5, 3-0, and 6-0 pM Pb2 + to control sera. These samples were spotted on filter paper and assayed. Lead addition was found to have no effect on arginase activity although 1-0 pM Pb2+ reduced UMPase activity by at least 50%.lo
Discussion
The correlation of In PbB with unextracted EP is as expected. Neither PbB or EP was significantly correlated with rbc arginase. The slope of the line relating In PbB and rbc arginase is essentially zero with no correlation at PbB < 1 9 PM (< 40 pg/dl) and no apparent trend for positive correlation at higher PbB. This is contrary to the report by Fukumoto et al of a tentative correlation of arginase with PbB < 1 9 pM (< 40ug/dl) and a significant correlation with PbB > 1-9 pM (>40 pg/dl). 2 Chmielnicka et al examined serum, rather than rbc, arginase activity as an index of hepatic damage secondary to lead exposure.'3 Sixty lead workers were divided into two groups based on PbB either greater or less than 19 pM (40 pg/dl). There was a significant increase in serum arginase in the high lead group. The mean PbB in our 16 workers of 2-2 pM (46 Mg/dl) was considered too low to test for a hepatotoxic effect on serum arginase activity.
In this study it was not possible to correlate variations in PbB with arginase activity, the in vitro addition of Pb to blood samples did not affect red cell arginase activity, and the time required for the nonautomated assay of arginase was clearly greater than 
